Patents by Inventor David Ledden

David Ledden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11850583
    Abstract: Devices, kits, and methods separating and metering a plasma sample from a patient's liquid test sample.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: December 26, 2023
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Aaron Kauffmann, David Ledden
  • Publication number: 20230400394
    Abstract: A method of increasing a concentration of an antigen of a respiratory virus is provided. The method includes preparing a sample containing a first concentration of the antigen; contacting the sample containing the first concentration of the antigen to a first material having a negatively-charged surface, thereby capturing an amount of the antigen with the first material; contacting a second material to the first material to transfer the antigen from the first material to the second material, the second material having an ionic strength sufficient to release the captured antigen from the first material into the second material; and obtaining a resulting solution containing the antigen in a second concentration. The second concentration of the antigen in the resulting solution is higher than the first concentration of the antigen in the sample. Numerous other aspects in accordance with this and other embodiments are provided.
    Type: Application
    Filed: October 19, 2021
    Publication date: December 14, 2023
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: David Ledden, Jeffrey Mayfield, Hollie Huff
  • Publication number: 20230228773
    Abstract: Devices, assemblies, and kits are disclosed for separating and/or metering a plasma sample from a patient's liquid test sample. Also disclosed are methods of producing and using same.
    Type: Application
    Filed: June 28, 2021
    Publication date: July 20, 2023
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Aaron Kauffmann, Jon Stradinger, David Ledden
  • Publication number: 20230210890
    Abstract: Compositions and methods of treating COVID-19 are disclosed. The compositions comprise heparin and/or one or more other negatively charged molecules.
    Type: Application
    Filed: April 13, 2021
    Publication date: July 6, 2023
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventor: David Ledden
  • Patent number: 11585808
    Abstract: Devices, methods, and kits for detecting at least two analytes present within a small volume single fluid sample obtained from patient for the creation of a multiplexed panel of the various analytes present within the single fluid sample are disclosed.
    Type: Grant
    Filed: February 12, 2021
    Date of Patent: February 21, 2023
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventor: David Ledden
  • Patent number: 11480558
    Abstract: A method and a device for determining the concentration of an analyte in whole blood is disclosed. In one embodiment, the method includes generating a plasma layer in the whole blood sample. Furthermore, the method includes exposing the plasma layer to light. The method also includes capturing light reflected from the plasma layer. Additionally, the method includes analyzing the reflected light to determine the concentration of the analyte.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: October 25, 2022
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Satish Kumar Dubey, Ashish Kumar Lal, Vishal Manjanath Prabhu, David Ledden
  • Patent number: 11460476
    Abstract: Devices, kits, and methods are disclosed for use in detecting a concentration of an analyte of interest in a patient's liquid test sample. The devices, kits, and methods employ the use of one or more solid reagent zones that includes at least one analytical reagent for detection of an analyte of interest. The solid reagent zone(s) also includes at least one dye for determining whether results obtained from the diagnostic assay for the at least one analyte of interest are biased or inaccurate due to a loss of volume of a liquid reagent during the dispensing of the liquid reagent.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: October 4, 2022
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Aaron Kauffmann, David Ledden, Chris Zimmerle, Jon Stradinger
  • Patent number: 11460475
    Abstract: A composition of a bilimbin stock and a method of preparation are provided. In one aspect of the invention, the composition includes a base solution. The composition further includes a carbonate salt. Additionally, the composition includes bilimbin. Furthermore, the composition includes human serum albumin.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: October 4, 2022
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Sudipa Galgalkar, Ishita Chakraborty, Ragavendar Ms, David Ledden
  • Publication number: 20220266241
    Abstract: Devices, kits, and methods separating and metering a plasma sample from a patients liquid test sample.
    Type: Application
    Filed: June 5, 2020
    Publication date: August 25, 2022
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Aaron Kauffmann, David Ledden
  • Publication number: 20220252578
    Abstract: A tangent flow hemolysis blood testing assembly, device and method are described herein. The presently disclosed and claimed inventive concept(s) relate to a device(s), kit(s), and method(s) for injecting a patient's liquid test sample into a reaction vessel. More specifically, the presently disclosed and claimed inventive concept(s) relate to an improved liquid test sample injection device that comprises a plug that forms an airtight seal that facilitates the active injection of a liquid test sample into a reaction vessel, and kits and methods of use related thereto.
    Type: Application
    Filed: December 5, 2019
    Publication date: August 11, 2022
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Aaron Kauffmann, David Ledden, Jennifer Samproni
  • Patent number: 11369314
    Abstract: Devices, kits, and methods for (a) determining the presence and/or concentration of at least one analyte(s) of interest present in a patient's fluid sample and devices and methods of calibration related thereto, and (b) preventing, mitigating, and/or eliminating biofouling of an indwelling, wearable biosensor are disclosed and/or claimed herein.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: June 28, 2022
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventor: David Ledden
  • Patent number: 11339419
    Abstract: Composition(s), device(s), kit(s), and method(s) for an improved analyte detection sensor(s) comprising at least one scavenger protein and method(s) of preserving the functioning and functional life of the improved analyte detection sensor(s).
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: May 24, 2022
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Janine Cox, Christopher Lawrence, Murli Narayan, David Ledden
  • Publication number: 20220143604
    Abstract: Microfluidic devices, method for making and using same are disclosed. The microfluidic device can be made by applying a reagent in liquid form into a sample treatment site within a substrate base. The substrate base has hydrophilic properties bordering a flow channel, and has an application site, the sample treatment site and an analytical site. The flow channel is sized and configured so as to draw a sample applied into the application site to the analytical site through the sample treatment site by capillary action. The reagent is freeze-dried within the sample treatment site.
    Type: Application
    Filed: March 12, 2020
    Publication date: May 12, 2022
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Aaron Kauffmann, Jeffrey Mayfield, David Ledden
  • Publication number: 20220137031
    Abstract: A blood testing assembly and method are described. In the method, a blood testing device having a plasma separation membrane and a reagent is connected to a syringe containing blood having blood cells and plasma. A blood sample of the blood is passed from the syringe through a plasma separation membrane within the blood testing device to separate the plasma from the blood cells. A reagent is saturated with the plasma, and then the reagent is colorimetrically analyzed to determine a degree of hemolysis within the blood sample.
    Type: Application
    Filed: December 5, 2019
    Publication date: May 5, 2022
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Jennifer Samproni, Aaron Kauffmann, David Ledden
  • Publication number: 20220043010
    Abstract: Non-limiting embodiments of a modified devices that comprise at least one dye for determining whether results obtained from the conductance of at least one diagnostic assay are biased, as well as kits and methods of use related thereto.
    Type: Application
    Filed: February 26, 2020
    Publication date: February 10, 2022
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Aaron Kauffmann, David Ledden, Chris Zimmerle, Jon Stradinger
  • Publication number: 20210382074
    Abstract: A composition of a bilimbin stock and a method of preparation are provided. In one aspect of the invention, the composition includes a base solution. The composition further includes a carbonate salt. Additionally, the composition includes bilimbin.
    Type: Application
    Filed: July 31, 2019
    Publication date: December 9, 2021
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Sudipa Galgalkar, Ishita Chakraborty, Ragavendar MS, David Ledden
  • Publication number: 20210282709
    Abstract: Devices, kits, and methods for (a) determining the presence and/or concentration of at least one analyte(s) of interest present in a patient's fluid sample and devices and methods of calibration related thereto, and (b) preventing, mitigating, and/or eliminating biofouling of an indwelling, wearable biosensor are disclosed and/or claimed herein.
    Type: Application
    Filed: June 7, 2017
    Publication date: September 16, 2021
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventor: David Ledden
  • Publication number: 20210285945
    Abstract: Devices, kits, and methods for determining the presence or absence of at least one analyte in a liquid test sample.
    Type: Application
    Filed: June 7, 2017
    Publication date: September 16, 2021
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: David LEDDEN, Lloyd SCHULMAN
  • Patent number: 11040350
    Abstract: Devices, kits, and methods for dispensing at least two liquid reagents for use in analyte(s) detection assays are disclosed.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: June 22, 2021
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventor: David Ledden
  • Publication number: 20210164972
    Abstract: Devices, methods, and kits for detecting at least two analytes present within a small volume single fluid sample obtained from patient for the creation of a multiplexed panel of the various analytes present within the single fluid sample are disclosed.
    Type: Application
    Filed: February 12, 2021
    Publication date: June 3, 2021
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventor: David Ledden